Article Text

53 An audit of heart-type fatty acid-binding protein (H-FABP) in acute cardiac admissions
  1. M Connolly,
  2. M Kinnin,
  3. D McEneaney
  1. Craigavon Area Hospital, Craigavon, UK


Introduction Heart-type Fatty Acid-Binding Protein (H-FABP) has previously been assessed for early diagnosis of ACS. H-FABP has a sensitivity of 85.3% 3 to 6 h after chest pain onset.1 H-FABP (>6.48 ng/ml) has been associated with significantly increased event rates. With the introduction of highly sensitive troponin T (hsTnT), Body et al. assessed 1,171 patients with suspected cardiac chest pain using a combination of H-FABP, hsTnT and ECG to rule-out ACS with a sensitivity of 99.1% and a NPV of 99.7%.

Methodology We prospectively evaluated H-FABP in early detection of ACS. Patients admitted with cardiac chest pain within 6 h onset were recruited. Baseline demographics, cardiac risk factors and a TIMI risk score were recorded. STEMI patients were excluded. Baseline blood samples were taken for H-FABP and hsTnT. A 6 h hsTnT was taken to confirm or exclude ACS diagnosis.

ACS was denoted as chest pain with or without ECG changes and a hsTnT rise of >20% from baseline sample or a delta rise of 7 ng/l (normal <14 ng/l). We assessed if baseline H-FABP >6.32 ng/ml (99th centile, IT assay) could predict ACS.

Results We enrolled 69 patients, 45 (65%) were male. Mean age was 66.8 years. ACS was diagnosed in 23 (32.9%) patients. Mean TIMI score was 3.29 in the ACS group and 3.07 in the non-ACS group. At baseline, median H-FABP was 8.61 vs. 6.45 (p = 0.01), median baseline hsTnT was 48 vs. 9 (p < 0.001) and median repeat hsTnT was 128 vs. 9 (p < 0.001), (Table 1). Sensitivity of H-FABP was 78.3% vs. 78.3% for baseline hsTnT, with specificity 44.7% vs. 63.8%, positive predictive value (PPV) 40.9% vs. 51.4% and negative predictive value (NPV) 80.8% vs. 85.7% (Table 2). Baseline H-FABP achieved an area under curve (AUC) of 0.69 vs. 0.77 for hsTnT. H-FABP and hsTnT combined achieved an AUC of 0.71. Of note, 28 (40.5%) had a ‘triple positive’ result, 9 (13.0%) patients had a raised H-FABP/both hsTnT samples negative, of which one developed ACS within 1 year requiring emergency percutaneous coronary intervention (PCI), 2 had angiography/PCI for ongoing symptoms, 1 had normal angiography despite chest pain and 5 had further investigation including echocardiography / exercise stress testing. In addition, 2 of 23 ACS (8.7%) patients had an initial positive H-FABP / negative baseline hsTnT/positive 6 h hsTnT. Furthermore, 18 (26.1%) had a ‘triple negative’ result.

Abstract 53 Table 1

Baseline data

Abstract 53 Table 2

Comparison of H-FABP/hsTnT

Baseline H-FABP had the same sensitivity but was less specific than hsTnT for single sample diagnosis. H-FABP has a role in early diagnosis of ACS, with a combination approach enabling identification of ACS in a select number of patients with baseline negative hsTnT/6 h positive hsTnT patients. H-FABP correctly identified 3 (33.3%) patients with both hsTnT negative results that had significant coronary disease requiring intervention.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.